EUVIMEDEUVIMED entdecken
Crossref

HCV genotype distribution in Istanbul: A detailed 7 year epidemiological overview and impact of Covid-19 pandemic

Begüm Nalça Erdin iD, Yüksel Akkaya, Arzu İrvem

Acta Microbiologica et Immunologica Hungarica · 2024

DOI: 10.1556/030.2024.02388 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Microbiologica et Immunologica Hungarica, 2024. Verfasst von Begüm Nalça Erdin und 2 weiteren Autor:innen. Beteiligte Einrichtung: 1Microbiology Department, Health Sciences University Darıca Farabi Training and Research Hospital, Kocaeli, Turkey. Hauptthemen laut MEDLINE: Hepacivirus, Genotype, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis C virus (HCV) is a leading cause of chronic liver disease, cirrhosis, and hepatocellular carcinoma worldwide. HCV has 8 genotypes (GT) and 86 subtypes and distribution of GTs varies based on geographical regions, transmission routes and even in cultural groups. The determination of viral genotype is crucial in choosing antiviral treatment, determining the duration of therapy, and monitoring treatment respose. Since 2014, with the usage of direct-acting antiviral agents (DAAs) in the treatment of HCV infections, a cure rate over 95% could be possible. Epidemiological data are important to combat a chronic HCV infections. Due to its geographical location, Turkey is like a bridge connecting Asia and Europe. Istanbul is the biggest and most crowded city of Turkey and has received immigration from many different countries, especially from Syria, in recent years and immigration still goes on. In addition, the COVID-19 pandemic has had devastating effects in our country. In this study, we determined the HCV genotypes in Health Sciences University Ümraniye Training and Research Hospital, in Istanbul between 2016 and 2022. Of the 322 patients analyzed during this 7-year period, HCV GT1b was the most prevalent GT in 65.2%, followed by GT3 in 15.5%, GT1a in 10.6%. Our data serve as a great mirror for HCV epidemiology in Turkey and contribute to global data.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepacivirusGenotypeCOVID-19HumansTurkeyFemaleMaleMiddle AgedAdultSARS-CoV-2AgedHepatitis CHepatitis C, ChronicAntiviral AgentsPandemicsYoung Adult

Stichwörter der Autor:innen

HCVTurkeygenotypesimmigrantstreatment

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • 1Microbiology Department, Health Sciences University Darıca Farabi Training and Research Hospital, Kocaeli, Turkey.
  • 2Microbiology Department, Health Sciences University Ümraniye Training and Research Hospital, Istanbul, Turkey.
  • 3Microbiology Department, Health Sciences University Kanuni Sultan Süleyman Training and Research Hospital, Istanbul, Turkey.

ORCID-Profile: Begüm Nalça Erdin

Zitieren

APA

Erdin, B. N., Akkaya, Y., & İrvem, A. (2024). HCV genotype distribution in Istanbul: A detailed 7 year epidemiological overview and impact of Covid-19 pandemic. Acta Microbiologica et Immunologica Hungarica. https://doi.org/10.1556/030.2024.02388

Vancouver

Erdin BN, Akkaya Y, İrvem A. HCV genotype distribution in Istanbul: A detailed 7 year epidemiological overview and impact of Covid-19 pandemic. Acta Microbiologica et Immunologica Hungarica. 2024. doi:10.1556/030.2024.02388

BibTeX
@article{Erdin2024,
  author = {Erdin, Begüm Nalça and Akkaya, Yüksel and İrvem, Arzu},
  title = {HCV genotype distribution in Istanbul: A detailed 7 year epidemiological overview and impact of Covid-19 pandemic},
  journal = {Acta Microbiologica et Immunologica Hungarica},
  year = {2024},
  doi = {10.1556/030.2024.02388}
}
Kostenlos starten →